Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Plos One|November 26, 2015
Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-CellsCody Paiva, J Claire Godbersen, Ryan S Soderquist, et al.
Oncotarget|August 9, 2015
Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myelomaMatthew B Siegel, Selina Qiuying Liu, Monika A Davare, et al.
American Journal of Clinical Pathology|August 16, 2014
Aberrations of MYC are a common event in B-cell prolymphocytic leukemiaEllen Flatley, Andy I Chen, Xiangrong Zhao, et al.
British Journal of Haematology|August 23, 2014
Otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR(™) therapeutic protein, for relapsed or refractory NHL patientsJohn M Pagel, Stephen E Spurgeon, John C Byrd, et al.
Medrxiv : the Preprint Server for Health Sciences|September 14, 2021
Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patientsZoe L Lyski, Sunny Kim, David Xthona Lee, et al.
Science Translational Medicine|September 2, 2016
Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemiaJessica T Leonard, Joelle S J Rowley, Christopher A Eide, et al.
Case Reports in Hematology|February 7, 2022
Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic LeukemiaZoe L Lyski, Myung Sun Kim, David Xthona Lee, et al.
Oncotarget|March 25, 2014
A potential therapeutic strategy for chronic lymphocytic leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitorRussell T Burke, Sarah Meadows, Marc M Loriaux, et al.
British Journal of Haematology|June 10, 2019
Phase 1-2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphomaStephen E Spurgeon, Kamal Sharma, David F Claxton, et al.
Cancer|May 26, 2018
Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinibMax J Gordon, Michael Churnetski, Hamood Alqahtani, et al.
Pageof 5